Free Trial
NASDAQ:BRTX

Biorestorative Therapies (BRTX) Stock Price, News & Analysis

Biorestorative Therapies logo
$1.50 +0.07 (+4.90%)
Closing price 10/3/2025 03:59 PM Eastern
Extended Trading
$1.46 -0.04 (-2.60%)
As of 10/3/2025 04:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Biorestorative Therapies Stock (NASDAQ:BRTX)

Advanced

Key Stats

Today's Range
$1.41
$1.51
50-Day Range
$1.41
$1.84
52-Week Range
$1.21
$2.55
Volume
44,933 shs
Average Volume
45,475 shs
Market Capitalization
$11.97 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Sell

Company Overview

Biorestorative Therapies Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
29th Percentile Overall Score

BRTX MarketRank™: 

Biorestorative Therapies scored higher than 29% of companies evaluated by MarketBeat, and ranked 804th out of 941 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Earnings Growth

    Earnings for Biorestorative Therapies are expected to grow in the coming year, from ($1.43) to ($0.86) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Biorestorative Therapies is -1.18, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Biorestorative Therapies is -1.18, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Biorestorative Therapies has a P/B Ratio of 1.22. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Biorestorative Therapies' valuation and earnings.
  • Percentage of Shares Shorted

    1.85% of the float of Biorestorative Therapies has been sold short.
  • Short Interest Ratio / Days to Cover

    Biorestorative Therapies has a short interest ratio ("days to cover") of 1.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Biorestorative Therapies has recently decreased by 24.51%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Biorestorative Therapies does not currently pay a dividend.

  • Dividend Growth

    Biorestorative Therapies does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.85% of the float of Biorestorative Therapies has been sold short.
  • Short Interest Ratio / Days to Cover

    Biorestorative Therapies has a short interest ratio ("days to cover") of 1.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Biorestorative Therapies has recently decreased by 24.51%, indicating that investor sentiment is improving significantly.
  • Search Interest

    Only 2 people have searched for BRTX on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • MarketBeat Follows

    2 people have added Biorestorative Therapies to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Biorestorative Therapies insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    30.80% of the stock of Biorestorative Therapies is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    69.38% of the stock of Biorestorative Therapies is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Biorestorative Therapies' insider trading history.
Receive BRTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biorestorative Therapies and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BRTX Stock News Headlines

Trump's Law S.1582: $21T Dollar Revolution Coming
Do you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. If you do…tc pixel
Earnings Outlook For BioRestorative Therapies
BioRestorative Therapies, Inc. (BRTX) - Yahoo Finance
See More Headlines

BRTX Stock Analysis - Frequently Asked Questions

Biorestorative Therapies' stock was trading at $1.43 on January 1st, 2025. Since then, BRTX stock has increased by 4.9% and is now trading at $1.50.

Biorestorative Therapies, Inc. (NASDAQ:BRTX) issued its quarterly earnings results on Tuesday, August, 12th. The company reported ($0.30) EPS for the quarter, topping the consensus estimate of ($0.41) by $0.11. The firm had revenue of $0.30 million for the quarter, compared to the consensus estimate of $0.34 million. Biorestorative Therapies had a negative net margin of 1,772.40% and a negative trailing twelve-month return on equity of 137.00%.
Read the conference call transcript
.

Biorestorative Therapies' Board of Directors initiated a share buyback program on Tuesday, June 17th 2025, which permits the company to repurchase $2,000,000 in outstanding shares, according to EventVestor. This means that the company could reacquire up to 15.9% of its shares through open market purchases. Shares buyback programs are typically an indication that the company's leadership believes its stock is undervalued.

Shares of BRTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Biorestorative Therapies investors own include NVIDIA (NVDA), Micron Technology (MU), PayPal (PYPL), Advanced Micro Devices (AMD), Avino Silver & Gold Mines (ASM), Broadcom (AVGO) and AstraZeneca (AZN).

Company Calendar

Last Earnings
8/12/2025
Today
10/05/2025
Next Earnings (Estimated)
11/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Healthcare
Current Symbol
NASDAQ:BRTX
CIK
1505497
Fax
N/A
Employees
7
Year Founded
1997

Profitability

EPS (Trailing Twelve Months)
($1.27)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$8.98 million
Net Margins
-1,772.40%
Pretax Margin
-1,772.40%
Return on Equity
-137.00%
Return on Assets
-88.31%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.07
Quick Ratio
2.07

Sales & Book Value

Annual Sales
$400 thousand
Price / Sales
29.93
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.23 per share
Price / Book
1.22

Miscellaneous

Outstanding Shares
7,980,000
Free Float
5,521,000
Market Cap
$11.97 million
Optionable
Not Optionable
Beta
-0.69

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:BRTX) was last updated on 10/5/2025 by MarketBeat.com Staff
From Our Partners